Science is fun


REKOM BIOTECH implements the new ISO 9001:2015 standard


Our commitment to ensure the highest quality level in the design and production of recombinant antigens continues after the implementation of the ISO:9001-2015 Standard.


REKOM BIOTECH enters the japanese market


Rekom Biotech signed a distribution agreement with the Japanese company Tokyo Future Style, Inc. The agreement was concluded on February 25th, 2014 and covers the territories of Japan, South Korea and Taiwan.

The new distributor Tokyo Future Style, Inc. will be in charge of introducing Rekom Biotech’s products to this great potential market which already exhibits high growth rates.


REKOM BIOTECH signs distribution agreement in India


Rekom Biotech and Biogeniux signed exclusive distribution agreement for marketing Rekom Biotech’s products in India on October 7th, 2013.

This agreement marks an important step towards consolidation of Rekom Biotech in the Indian market, which is a priority objective due to the focus of Rekom on neglected diseases with a high impact on this region.


REKOM BIOTECH presents its products to a Government delegation from the Kingdom of Morocco


Rekom Biotech in Morocco

On March 21st, 2012 Rekom Biotech presented the company and its products to a Government delegation from the Kingdom of Morocco. The delegation included the Rector of Hassan I University of Settat Professor Ahmed Nejmeddine, Health Regional Director for the region Tanger-Tetuan of Health Minister Dr. Abdelkrim Meziane Belfkih, Dean of Fèz Medicine Faculty Professor My. H. Farih, General Director of Ibno Rochd University Hospital of Casablanca Professor Afif, My Hicham and the Equipment and Supply Director M. El Amm.

The meeting was held in the framework of the visit of this delegation of the Government of Morocco to Granada. During their stay in the city they have met the Health Sciences Technological Park (PTS) and University of Granada with the objective of transferring operations model of both institutions to the new Health Sciences Institute that will be inaugurated in Morocco soon.


REKOM BIOTECH has been granted an award (GREIB) in order to develop the validation of recombinant antigens as infectious diseases biomarkers


The translational project called "Validation of proteins Tpp17, Tpp15 and Tpp47 for the detection of protein biomarkers for syphilis" has been awarded a grant on July 22th, 2011 from the International Excellence Campus, R&D&I and Transfer Subprogramme "Granada Research of Excellence Initiative on BioHealth" (GREIB).

In the frame of this project and collaborating with University of Granada, Rekom Biotech developed a system aimed at facilitating the translation of results from research to clinical practice. The system is focused on the application of both chemometric techniques and physical-chemical methods to serological assays.